These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

303 related articles for article (PubMed ID: 19539072)

  • 81. Contrast-induced nephropathy in patients undergoing primary angioplasty for acute myocardial infarction.
    Marenzi G; Lauri G; Assanelli E; Campodonico J; De Metrio M; Marana I; Grazi M; Veglia F; Bartorelli AL
    J Am Coll Cardiol; 2004 Nov; 44(9):1780-5. PubMed ID: 15519007
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Risk score for the prediction of contrast-induced nephropathy in elderly patients undergoing percutaneous coronary intervention.
    Fu N; Li X; Yang S; Chen Y; Li Q; Jin D; Cong H
    Angiology; 2013 Apr; 64(3):188-94. PubMed ID: 23196639
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Contrast nephropathy in high-risk patients undergoing coronary angiography and intervention.
    Uddin MA; Rabbani MA; Jafary FH; Bhatti MA; Islam M
    J Coll Physicians Surg Pak; 2005 Dec; 15(12):791-4. PubMed ID: 16398973
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Percutaneous coronary intervention causes increase of serum cystatin C concentration even in the patients with a low risk of contrast-induced nephropathy.
    Tanaga K; Tarao K; Nakamura Y; Inoue T; Jo K; Ishikawa T; Miyazaki A
    Cardiovasc Interv Ther; 2012 Sep; 27(3):168-73. PubMed ID: 22692693
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Effect of hydration with or without n-acetylcysteine on contrast induced nephropathy in patients undergoing coronary angiography and percutaneous coronary intervention.
    Awal A; Ahsan SA; Siddique MA; Banerjee S; Hasan MI; Zaman SM; Arzu J; Subedi B
    Mymensingh Med J; 2011 Apr; 20(2):264-9. PubMed ID: 21522098
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Increased urinary adiponectin level is associated with contrast-induced nephropathy in patients undergoing elective percutaneous coronary intervention.
    Zhang JY; Wang Q; Wang RT; Li F; Cheng HX; Lian K; Liu Y; Tao L
    BMC Cardiovasc Disord; 2019 Jul; 19(1):160. PubMed ID: 31269899
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Recombinant Brain Natriuretic Peptide for the Prevention of Contrast-Induced Nephropathy in Patients with Chronic Kidney Disease Undergoing Nonemergent Percutaneous Coronary Intervention or Coronary Angiography: A Randomized Controlled Trial.
    Liu J; Xie Y; He F; Gao Z; Hao Y; Zu X; Chang L; Li Y
    Biomed Res Int; 2016; 2016():5985327. PubMed ID: 26949703
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Incidence of contrast material-induced nephropathy after neuroendovascular procedures.
    Prasad V; Gandhi D; Stokum C; Miller T; Jindal G
    Radiology; 2014 Dec; 273(3):853-8. PubMed ID: 25102293
    [TBL] [Abstract][Full Text] [Related]  

  • 89. The efficacy of probucol combined with hydration in preventing contrast-induced nephropathy in patients with coronary heart disease undergoing percutaneous coronary intervention: a multicenter, prospective, randomized controlled study.
    Fu N; Yang S; Zhang J; Zhang P; Liang M; Cong H; Lin W; Tian F; Lu C
    Int Urol Nephrol; 2018 Jan; 50(1):105-112. PubMed ID: 29071556
    [TBL] [Abstract][Full Text] [Related]  

  • 90. [The relationship between hyperuricemia and contrast-induced nephropathy in patients with chronic kidney disease undergoing percutaneous coronary intervention].
    Liu YH; Tan N; Liu Y; Ye P; He YT; Ran P; Jiang L
    Zhonghua Xin Xue Guan Bing Za Zhi; 2013 Sep; 41(9):740-3. PubMed ID: 24331800
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Outcomes of contrast-induced nephropathy: experience in patients undergoing cardiovascular intervention.
    McCullough P
    Catheter Cardiovasc Interv; 2006 Mar; 67(3):335-43. PubMed ID: 16489569
    [TBL] [Abstract][Full Text] [Related]  

  • 92. N-Terminal Fragment of Pro B-type Natriuretic Peptide as a Marker of Contrast-Induced Nephropathy After Primary Percutaneous Coronary Intervention for ST-Segment Elevation Myocardial Infarction.
    Goussot S; Mousson C; Guenancia C; Stamboul K; Brunel P; Brunet D; Touzery C; Cottin Y; Zeller M
    Am J Cardiol; 2015 Sep; 116(6):865-71. PubMed ID: 26183794
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Contrast-induced nephropathy: controlled study by differential GFR measurement in hospitalized patients.
    Erselcan T; Egilmez H; Hasbek Z; Tandogan I
    Acta Radiol; 2012 Mar; 53(2):228-32. PubMed ID: 22139722
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Remedial hydration reduces the incidence of contrast-induced nephropathy and short-term adverse events in patients with ST-segment elevation myocardial infarction: a single-center, randomized trial.
    Luo Y; Wang X; Ye Z; Lai Y; Yao Y; Li J; Liu X
    Intern Med; 2014; 53(20):2265-72. PubMed ID: 25318787
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Prediction of Contrast-Induced Nephropathy With Persistent Renal Dysfunction and Adverse Long-term Outcomes in Patients With Acute Myocardial Infarction Using the Mehran Risk Score.
    Wi J; Ko YG; Shin DH; Kim JS; Kim BK; Choi D; Ha JW; Hong MK; Jang Y
    Clin Cardiol; 2013 Jan; 36(1):46-53. PubMed ID: 23027701
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Remote ischemic preconditioning for prevention of contrast induced nephropathy-Insights from an Indian study.
    Valappil SP; Kunjukrishnapillai S; Viswanathan S; Koshy AG; Gupta PN; Velayudhan RV; Iype M
    Indian Heart J; 2018; 70(6):857-863. PubMed ID: 30580857
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Incidence of contrast nephropathy in patients receiving comprehensive intravenous and oral hydration.
    Mueller C; Seidensticker P; Buettner HJ; Perruchoud AP; Staub D; Christ A; Buerkle G
    Swiss Med Wkly; 2005 May; 135(19-20):286-90. PubMed ID: 15986266
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Acute renal haemodynamic effects of radiocontrast media in patients undergoing left ventricular and coronary angiography.
    Möckel M; Radovic M; Kühnle Y; Combé V; Waigand J; Schröder S; Dietz R; Frei U; Eckardt KU
    Nephrol Dial Transplant; 2008 May; 23(5):1588-94. PubMed ID: 18175785
    [TBL] [Abstract][Full Text] [Related]  

  • 99. [Association between high-sensitivity C-reactive protein and contrast-induced nephropathy after primary percutaneous coronary intervention].
    He YT; Tan N; Liu YH; Chen SQ; Liu Y; Huang SJ; Yang DH; Ye P; Ran P
    Zhonghua Xin Xue Guan Bing Za Zhi; 2013 May; 41(5):394-8. PubMed ID: 24021122
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Association of central pulse pressure with contrast-induced nephropathy and clinical outcomes in patients undergoing coronary intervention.
    Huang SS; Huang PH; Leu HB; Wu TC; Lin SJ; Chen JW
    J Hypertens; 2013 Nov; 31(11):2187-94. PubMed ID: 23868087
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.